Legalisation should not come at the cost of patient care. Unfortunately, in many jurisdictions, that’s precisely what happened. Germany must do better. With an estimated 200.000 medical cannabis patients and an additional estimated 600.000 self-paying consumers, Germany’s legal cannabis system today serves nearly 800.000  individuals – and their access cannot be left to chance. 

We’re seeing this tension play out in real time: overwhelmed doctors, pharmacy stockouts, and rising confusion about what’s medical, what’s recreational, and what’s simply unavailable. That’s why we advocate for solutions like an over-the-counter (OTC)  product with a moderate THC content – around 10%. It would offer relief for many common conditions like insomnia, anxiety, and chronic pain, while reducing pressure on physicians and preserving clinical oversight via pharmacies.